Clinical Trials Browser

Unknown × Immunohistochemistry × Thoracic × Clear all

NCT03078959 2017-03-14

Prognostic Value of PD-L1 in NSCLC

Carcinoma, Non-Small-Cell Lung

NCT00899262 2013-08-26

Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers

Lung Neoplasms, Tobacco Use Disorder

NCT00989690 2013-08-12

Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00801385 2009-08-25

Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms